|
US3325364A
|
|
Process for stabilizing enzyme compositions
|
|
US3270024A
|
|
Heterocyclic amino phenoxyacetic acid amides, acid addition salts, and quaternary ammonium salts thereof
|
|
US3396193A
|
|
Halogenated cis-cinnamic acids
|
|
US3335147A
|
|
Anilino-pyridinium-maleimides
|
|
US3329508A
|
|
Artificial sweetening compositions containing choline
|
|
US3119823A
|
|
Process for preparation of o-hydroxyphenyl-triazines
|
|
US3232939A
|
|
Pyridylethyl-barbituric acids
|
|
US3121724A
|
|
Aminoalkyl ethers of 6-halobenzyl-5-indanol and 7-halobenzyl-4-indanol
|
|
US3193458A
|
|
Method of lowering blood cholesterol level
|
|
US3129225A
|
|
Novel 4-oxy-3-maleimidyl betaines
|
|
US3182064A
|
|
alpha-[2-(4-pyridyl)ethyl]aminopropionic acid derivatives
|
|
US3131128A
|
|
Anti-viral biguanides
|
|
US3150139A
|
|
Nu-methylpiperazinocyclohexanol derivatives
|
|
US3180867A
|
|
Piperazine derivatives
|
|
US3115524A
|
|
Bicycloheptyl, aralkyl-ureas
|
|
US3062819A
|
|
1-[(2-amino-4-substituted amino-1, 3, 5-triazinyl-6-yl)methyl], 1, 1-dialkyl hydrazinium salts
|
|
US3081302A
|
|
Certain-p-acetaminophenoxyacetamido derivatives
|
|
US3152181A
|
|
Alkoxypropylene biguanides
|
|
US3183230A
|
|
Haloaralkyl biguanides
|
|
US3147271A
|
|
Nu1-pyridylalkyl-n5-substituted biguanides
|
